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response to drug treatment or potentially life-threatening
arrhythmias. It may also be considered in a young patient in
order to avoid lifelong dependence on anti-arrhythmic drugs.
This is becoming an increasingly common indication for SUI-
gery in view of the excellent results now obtained in major
centres.3•4 However, appropriate surgical experience is essential
and, as the number of such cases requiring surgery is limited,
surgery should only pe offered at a few major centres. This
article reports on the first 9 such patients operated on at
Groote Schuur Hospital, and outlines the rationale for such
treatment.
The WPW syndrome
The association of paroxysmal tachycardias in otherwise healthy
young people with the characteristic ECG pattern of a short
P-R interval and a wide QRS complex with slurred upstroke
(delta wave) (Fig. 1) was described in 1930 by the authors
whose names are now indelibly attached to this syndrome.s It
has fascinated electrophysiologists over the years because it is
the best understood clinical example of the phenomenon of
re-entry. An abnormal bridge of muscular tissue crossing the
AV groove, capable of conducting impulses more rapidly than
the AV node, causes early activation of the ventricle and
accounts for the delta wave. The wide QRS complex is due to
fusion of the impulse activating the ventricle via the accessory
pathway (AP) with the normal impulse arriving later via the
AV node.
S AI, Med J 1991; 79: 583-587.
Surgical division of accessory atrioventricular (AV) connec-
tions has been performetl on 9 patients with the Wolff-
Parkinson-White (WPW) syndrome at Groote Schuur Hospital.
All patients had symptomatic paroxysmal tachycardia. The
indication for surgery in 5 patients was poor control on anti-
arrhythmic drugs. Surgery was performed on a 15-year-old
boy to prevent lifelong dependence on drugs, although his
atrial fibrillation (ventricular rate> 300/min) was controllable
with sotalol 1 280 mg daily. The remaining 3 patients required
cilrdiac surgery for other indications and therefore their
accessory pathways (APs) were divided concurrently. The
AP was localised by pre-operative endocardial mapping and
intra-operative epicardial mapping. There were 4 postero-
septal, 3 left free-wall and 2 right free-wall pathways. An
endocardial approach was used to divide the pathways.
All 5 free-wall APs were successfully divided without com-
plications or recurrence. However, 1 patient with paroxysmal
atrial fibrillation and severe unstable angina·due to coronary
artery disease died unexpectedly 10 days after 4-vessel
coronary bypass grafting and division of a posteroseptal AP.
Postoperative complications occurred in a further 2 patients
with posteroseptal APs. One patient developed complete
heart block and is now asymptomatic with a DDD pacemaker,
while the other had recurrence of retrograde bypass con-
duction postoperatively, but is now successfully controlled
on sotalol. Therefore 7 of the 8 survivors are free of recurrence
of tachycardia on no anti-arrhythmic drugs after a mean
follow-up of 14,3 months. New insights into the surgical
technique, particularly for division of posteroseptal pathways,
can be expected to improve the outlook.
Surgery for the Wolff-Parkinson-White syndrome
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Fig. 1. ECG of patient 5 taken during sinus rhythm demonstrating
the typical features of the WPW pattern, namely a short P-R
interval (0,12 s) and a widened (0,16 s) QRS complex. The
widening is due to the slurred initial upstroke (delta wave)
resulting from fusion of the atrial impuls.e conducted via the AP
that depolarises part of the ventricle prematurely, with that of the
normal implJlse conducted via the AV node. The negative delta
waves in the inferior leads give the false impression of inferior
myocardial infarction.
Under certain conditions an impulse may fail to conduct via
the AP and the impulse conducted via the AV node may then
enter the AP retrogradely from below, thus re-exciting the
Surgical division of the accessory atrioventricular (AV) connec-
tions in patients with the Wolff-Parkinson-White (WPW)
syndrome was pioneered by Sealy and his colleagues from
Duke University in North Carolina and reported in 1968. 1
That institution has remained in the forefront of surgical
treatment of this condition, but such surgery is now widely
practised throughout the world. Before 1981, the failure rate
of WPW surgery was 14 - 30%.2 However, with experience
and modified techniques, the success rate has now increased to
100% in some centres.3
The WPW syndrome is an uncommon condition (1 - 3
cases/l 000 population) and surgery has been undertaken
mainly in those patients with severe symptoms, inadequate
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atrium and a circus movement tachycardia results. Conduction
via the AP is usually in the retrograde direction during the
tachycardia, hence activation of the ventricle will be normal
and the delta wave is therefore not visible during the tachy-
cardia. These tachycardias are characteristically sudden in
onset, may be very rapid and may stop abruptly, either
spontaneously or as a result of vagal stimulation that interrupts
the impulse in the AV node. If the tachycardia persists it will
be necessary to terminate it either by synchronised DC cardio-
version or administration of an anti-arrhythmic agent.
The other major and potentially more serious complication
of the WPW syndrome is the occurrence of atrial fibrillation
(AF). This occurs in about 30% of symptomatic patient.s even
in the absence of other heart disease. 6 The reason for this is
poorly understood. However, in the presence of AF the ventri-
cular rate may be extremely rapid because the protective fIlter
of the AV node is bypassed, and a high proportion of the
impulses may be rapidly conducted via the AP to the ventricle
(Fig. 2). In certain instances this may result in ventricular
fibrillation. Although the incidence of sudden death in this
syndrome appears to be low, it it more likely if the refractory
period of the AP is short and if the shortest R-R interval
during atrial fibrillation is less than 205 ms. 7 Such patients
may be identified by means of electrophysiological studies
Fig. 2. The ECG at initial presentation of patient 4 showing the
extremely rapid (300/min), irregular, bizarre wide QRS complex
tachycardia. This was due to AF conducting predominantly via
the AP. The shortest R-R interval was 140 ms.
(EPS), which consist in recording intracardiac ECG signals via
electrode catheters and studying the effects of programmed
stimulation delivered by specially constructed external pace-
TABLE I. PATIENT CHARACTERISTICS
Date of Age Previous drug
Patient surgery . (yrs) Sex Symptoms therapy Arrhythmia Other disease Indications for" surgery
17 Nov. 32 M Palpitations, Disopyramide AVRT Mixed aortic Aortic valve
1987 chest pain, valve replacement
dyspnoea
2 18 Nov. 46 M Palpitations, Disopyramide, AVRT AF None AF with rapid




3 4 Oct. 1988 10 F Palpitations, None AVRT Primum ASD Mitral valve
dyspnoea repair 1982; replacement
severe mitral
regurgitation
4 13 April 15 M Palpitations Digoxin, AF None Risk of ventricular
1988 verapamil, AVRT fibrillation;. to avoid
sotalol dependence on anti-
arrhythmic drugs
5 12 May 24 F Palpitations Disopyramide, AVRT None Poor control with
1989 trblocker, drugs; lack of
digoxin, availability of drugs;
verapamil, to avoid drugs
amiodarone, during future
sotalol .pregnancies
6" 24 May 6 F Palpitations Digoxin, AVRT None Poor control with
1989 ,a-blocker, drugs
sotalol
7" 4 Aug. 1989 30 F Palpitations, Digoxin, AVRT None Poor control with
chest pain verapamil, drugs
amiodarone
8 23 Aug. 54 M Angina, Sotalol, AF IHD Coronary bypass
1989 dizziness disopyramide, graft for severe
disopyramide angina
+ verapamil
9 19 Oct. 37 F Palpitations, Digoxin, AVRT None Poor control with
1989 dizziness ,a-blocker, drugs
verapamil,
amiodarone
• Concealed accessory pathway; IHD = ischaemic heart disease; ASO = atrial septal defeat.
Patients and methods
Fig. 3. Diagrammatic representation of a transverse section of the
heart above the AV valves, to show the four main areas in which
APs occur. The numbers refer to the distribution of APs in our
patients (PA = pulmonary artery; AO = aorta; MV = mitral valve;
CS = coronary sinus; TV = tricuspid valve).
Results (Table 11)
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Immediate
In one patient with a concealed free-wall AP (patient 7)
there was no evidence of accessory pathway function intra-
operatively. The surgical dissection was therefore carried out
on the basis of the pre-operative endocardial mapping. There
has been no evidence of return of AP conduction and she has
been free of tachycardia for 8 months on no therapy, having
had frequent episodes before surgery despite anti-arrhythmic
drugs. In the other 8 patients, the AP was initially mapped
intra-operatively and no AP conduction could be demonstrated
after surgical division of these sites. However, AP conduction
returned within 24 hours with recurrence of tachycardia in 1
patient (No. 6) who had a concealed posterosepfal pathway.
The location of the accessory pathway was mapped at the
time of EPS via the electrode catheters by recording local
retrograde atrial activation times at various positions in the
coronary sinus and around the tricuspid valve ring during
induced AVRT or right ventricular pacing. Biplane cine films
were tak'en to assist in localisation of the electrodes at each
recording site in an attempt to correlate the activation times as
accurately as possible with the cardiac anatomy.
At operation, mapping was repeated on cardiopulmonary
bypass while at normothermia. A hand-held probe was
positioned sequentially around the atrial s"ide of the AV groove
during AVRT or right ventricular pacing. The site where the
earliest atrial activation was recorded was taken to be the site
of insertion of the AP. Mter analysing the traces, the surgeon
proceeded with the dissection of the dermed area. An endo-
cardial surgical approach4 was used with the heart artested
with cold crystalloid cardioplegia. Valve replacement and
coronary bypass grafting was done before AP dissection in the
3 patients undergoing these procedures. On completion of the
surgical procedure, after the heart was re-warmed and once
beating at normothermia, mapping was repeated to confirm
successful interruption of the accessory pathway.
A limited EPS was done within 1 week of the operation
using temporary atrial and ventricular epicardial pacing wires
(inserted at the time of surgery). A complete EPS using
electrode catheters was repeated 1 - 3 months postoperatively
in all except the 1 patient who died and the patient who
remained in complete heart block.
Complications
Complete heart block was initially present at the end of the
operation in 3 of the 4 patients with posteroseptal pathways.
However, it recovered spontaneously in 1 patient (No. 5), and
normal AV nodal refractoriness and conduction during rapid
atrial pacing was found at follow-up EPS. Patient 8 died
unexpectedly on the lOth postoperative day from a probable
myocardial infarction, after saphenous vein grafting of the
coronary arteries and division of a posteroseptal AP. Post-
"operatively, this patient was paced satisfactorily because of
atrial fibrillation with complete heart block and a ventricular
escape rhythm of 70/min. Patient 2 remained in complete
heart block with intermittent recovery of AV conduction
(without delta waves) and a permanent DDD pacemaker was
implanted. Patient 3, in whom a right-sided AP was divided in
addition to a mitral valve replacement, required repeat thoraco-
tomy for bleeding. Her postoperative recovery was slow because
of right ventricular dysfunction and tricuspid regurgitation,
but she subsequently did well.
These early results are similar to the first reported results
from major centres2 where, having developed surgical expertise,









The characteristics of the 9 patients are listed in Table I.
There were 4 male subjects and 5 female subjects, ranging in
age from 6 years to 54 years (mean 28,2 years). All had
symptoms of paroxysmal tachycardias. Delta waves were
present in 7 patients, whereas in 2 (patients 6 and 7), the APs
were concealed (no delta waves), but conducted retrogradely
during paroxysmal tachycardia.
Five patients remained symptomatic despite 3 - 6 drug trials
(mean 3,8) including arniodarone in 4 and sotalol in the other.
Three required cardiac surgery for other reasons (valve replace-
ment in 2- and 4-vessel coronary bypass grafting in 1), and so
the opportunity was used to divide the APs at the same time.
Finally, patient 4, a IS-year-old boy, presented in atrial fibril-
lation with an extremely rapid ventricular response (over
300/min) and a shortest pre-excited R-R interval of 140 ms
(Fig. 2). It was possible to prevent induction of atrioventricular
re-entry tachycardia (AVRT) and rapid AF with large doses of
sotalol (1280 mg daily). However, we recommended surgery
in his case to avoid a possible lifetime risk of sudden death and
dependence on anti-arrhythmic drugs. The location of the AP
was posteroseptal in 4 patients, left free wall in 3, and right
free wall in 2 (Fig. 3).
makers. 6 Such studies are used to characterise the AP and to
assess the response to treatment. If surgery is considered, EPS
is essential in order to map the location of the bypass tract. In
addition, if surgical division of the pathway is undertaken it is
localised intra-operatively by electrical mapping as the path-
ways are invisible to the surgeon. A high degree of co-
operation between the cardiac surgeon and the electrophysio-
logist is therefore essential.
Electrophysiological testing was done using standard tech-
niques.8 Briefly, multiple electrode catheters were inserted via
the femoral and subclavian veins and positioned in the heart to
record electrograms from the His bundle, right ventricle, right
atrium and left atrium via the coronary sinus. Programmed
electrical stimulation was used to determine refractory periods
and to induce reciprocating tachycardia and AF.
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TABLE 11. RESULTS
AP function
Patient Site of AP Surgery Complications Early Late Arrhythmia Symptoms Treatment Follow-up
1 R free Aortic valve None None Retro- None None Warfarin Well at 30
wall replacement, grade moo
AP dissection only
2 Postero- AP dissection CHB None None CHB, None ODD Well at
septal intermittent pacemaker 25 moo
AF
3 R free Mitral valve Postoperative None None None None Warfarin, Well at 1
wall replacement; haemorrhage diuretic mo., lives




4 L free wall AP dissection None None None None None None Well at
24 moo
5 Postero- AP dissection Transient CHB None None None None None Well at
septal 23 moo
6 Postero- AP dissection None Present Present AVRT Palpitations Sotalol Well at
septal 13 moo
7 L free wall AP dissection None None None None None None Well at
a moo
a Postero- Coronary CHB, died None CHB Temporary Died 10th
septal artery bypass 10th post- pacemaker day
graft, AP operative day;
dissection myocardial
infarction
9 L free wall AP dissection None' None None None None None We!' at
3 moo
CHB ~ complete heart block,
Late
The 8 survivors have been followed up for 1 - 30 months
(mean 14,3 months). Patient 3 lives in Botswana and has, not
yet returned for follow-up.
Five patients have been free of arrhythmias on no anti-
arrhythmic drugs. p'atient 2 has a permanent DDD pacemaker
and has had several episodes of atrial fibrillation (his predomi-
nant pre-operative arrhythmia) in the first few months after
surgery. No conduction to the ventricles occurred but the
pacemaker rate increased because of sensed atrial activity. He
is 'therefore on a small dose of ,B-blockers. However, his
quality of life is markedly improved compared to the frequent
pre-operative palpitations and syncope, which did not respond
to drugs.
Recurrence of AVRT has occurred in 1 patient (No. 6) as a
result of the return of retrograde conduction through her
concealed, posteroseptal AP. However, the arrhythmias are
now easily controlled on sotalol.
Discussion
This small series is the first report of surgical treatment of the
WPW syndrome in South Africa. The results are encouraging,
particularly in the patients with free-wall APs, since no major
complications or recurrences occurred in this group.
We encountered an unusually high proportion of patients
with posteroseptal APs. Successful division of APs in this
location is more difficult and requires extensive dissection in
the triangle of Koch, adjacent to the AV node, arid carries a
higher risk of heart block.2 Experience and new insights into
the surgical techniques should help to improve these results.
The decision to divide the AP surgically in a patient with
the WPW syndrome depends on a number of factors:
1. Severe symptoms not adequately controlled by carefully
chosen drug therapy.
The choice of anti-arrhythmic agents should be guided by
the functional characteristics of the bypass tract and the ability
of the chosen agent to suppress inducible tachycardias. If no
available drug adequately suppresses symptomatic tachycardias
or is not tolerated because of side-effects, surgery should be
seriously considered. Five of our 9 patients fell into this
category. In these cases, surgery offers relief of symptoms' that
medical treatment cannot. In severe cases, such as patient 2,
even long-term dependence on a pacemaker is preferable to
the incapacitating symptoms of the WPW syndrome.
2. Potentially life-threatening arrhythmias.
Patient 4 presented with AF (Fig. 2) accompanied l:iy an
extremely rapid ventricular response. The shortest R-R interval
of 140 ms indicates a significant risk of the arrhythIiua degene-
rating into ventricular fibrillation. 7 Although we' were able to
demonstrate that large doses of sotalol could alter the ,AP
refractoriness sufficiently to render this much less likely,9 we
felt that surgery offered a bener long-tei-m alternative by
eliminating the risk and removing the need for long-term drug
treatment in an otherwise healthy young boy.
3. Life-long dependence on anti-arrhythmic drugs.
Successful surgery will eliminate the need for anti-arrhyth-
mic drugs and is likely to be cost-efficient, particularly in
young people with otherwise normal hearts. It should be
considered particularly in young women before they have
children. Patient 5 illustrates this indication as, in addition to
poor control with the drugs that had been tried, she lives in a
neighbouring country where many such agents are not avail-
able. She is also keen to have children and would prefer not to
be on any drugs during pregnancy.
4. As an adjunct to other necessary open heart surgery.
Although patients 1 and 3 could have been treated medically
for their arrhythmias, both had easily accessible APs that
could be divided with linle additional risk at the time of valve
replacement. Patient 8 had severe coronary artery disease with
disabling angina, which was aggravated by very rapid heart
rates during AF. His postoperative death was myocardial in
nature rather than arrhythmic, and it is unlikely that the
additional cardiopulmonary bypass and ischaemic cross-elamp
times required for the AP dissection contributed to his death,
since he had been recovering well before his unexpected death
on the 10th postoperative ·day.
5. The availability of the necessary equipment and expertise.
Surgery for arrhythmias can only be undertaken in a unit
staffed by personnel with experience in electrophysiology and
equipped to do detailed endocardial mapping. IO This is essen-
tial, since the decision to operate will be influenced by the
characteristics of the pathway, its location and the possibility
of more than one AP that may be present in up to 20% of
patients. ll In addition to the necessary surgical skills, the
surgeon must also be familiar with the electrophysiological
techniques involved and be prepared to undertake the detailed
intra-operative mapping necessary to locate the AP and to
confirm that it has been successfully divided. This requires a
great deal of co-operation between surgeon, eleetrophysiologist
and technologist.
Excellent results are being obtained in units doing large
numbers of procedures 12 but are also satisfactory in those
doing smaller numbers,13 although there clearly is a learning
curve.7 It has recently become clear, since one of us (U.V.O.)
visited Dr James Cox's unit in St Louis, Mo., USA, that there
have been major advances both in intra-operative mapping
and in surgical technique in the last few years, which can be
expected to markedly improve the results of surgery for the
WPW syndrome. These include computerised mapping that
allows for instantaneous analysis of a single beat (thus improv-
ing intra-operative mapping), dissection of the entire anatomical
space in which the AP is located (because of the high incidence
of multiple pathways), and the use of cryosurgery.14
A start has been made in offering WPW surgery in South
Africa. In the·future, with the application of these new
techniques, we hope to emulate the outstanding results obtained
in leading centres.
Inevitably, when reports of techniques such as this are
presented at this stage of the evolution of health care resources
in this country, questions of cost-benefit will be raised. All
patients with symptomatic WPW syndrome should undergo
EPS to assess risk and the response to anti-arrhythmic drugs.
Those young patients that require lifelong drug treatment with
all the risks of side-effects of these expensive, relatively toxic
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agents, should be offered surgery. The benefits to the health
system are considerable, since curative surgery will avoid the
costs of many (perhaps 30) years of ailti-arrhythmic therapy,
multiple re-admissions to hospital for the treatment of break-
through arrhythmias and drug failures. In addition, the risks
of suddell death, estimated to be as high as 15% by J. COX er
al. (personal communication), are avoided. However, if we are
to obtain results similar to those reported internationally,
much of our custom-built equipment will need to be replaced
by commercially available computerised equipment to facilitate
pre- and intra-operative mapping.
Mr L. W. Piller provided invaluable expert technical assistance,
induding the manufacture of the probes used for intra-operative
mapping. We thank the Medical Superintendent of Groote Schuur
Hospital for permission to publish.
Addendum
Since submission of this manuscript, a further 5 APs have
been successfully divided without complications in 4 patients
(l right free wall and posteroseptal with Ebstein's anomaly, I
anteroseptal, 1 right free wall and 1 left free wall).
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